Table 3.
Dapagliflozin Group (n = 42) | Control Group (n = 38) | Adjusted Difference Between Groups | ||||||
---|---|---|---|---|---|---|---|---|
Baseline | 24 Weeks | P | Baseline | 24 Weeks | P | Mean (95% CI) | P | |
24-hour Holter-ECG findings | ||||||||
PVBs per hour, n | 15.9 ± 20.7 | 11.3 ± 17.6 | <.001 | 15.1 ± 21.1 | 14.4 ± 20.1 | .519 | −3.89 (−7.61, −0.16) | .041 |
PVBs percent | 0.329 ± 0.424 | 0.233 ± 0.351 | <.001 | 0.315 ± 0.426 | 0.304 ± 0.423 | .280 | −0.084 (−0.158, −0.011) | .025 |
Mean heart rate, beats/minute | 81.6 ± 6.0 | 82.4 ± 6.2 | .414 | 81.0 ± 5.4 | 81.6 ± 5.9 | .417 | 0.083 (−2.244, 2.409) | .944 |
Mean RR interval, ms | 746.1 ± 64.4 | 748.9 ± 65.2 | .785 | 749.7 ± 65.7 | 751.0 ± 66.8 | .933 | 1.45 (−34.24, 37.14) | .936 |
Heart rate variability parameters | ||||||||
SDNN, ms | 102.1 ± 25.1 | 113.1 ± 29.5 | <.001 | 100.3 ± 24.1 | 102.6 ± 23.4 | .067 | 8.79 (2.76, 14.82) | .005 |
SDANN, ms | 85.1 ± 22.4 | 92.3 ± 27.4 | .006 | 82.9 ± 23.7 | 84.1 ± 23.3 | .380 | 6.11 (0.41, 11.81) | .036 |
SDNN index, ms | 31.2 ± 15.4 | 35.9 ± 17.4 | .003 | 31.0 ± 13.2 | 31.5 ± 12.6 | .141 | 4.16 (1.01, 7.32) | .010 |
RMSSD, ms | 41.6 ± 28.3 | 49.9 ± 28.4 | .001 | 39.2 ± 27.6 | 40.6 ± 26.2 | .099 | 6.95 (1.19, 12.70) | .019 |
pNN50, % | 4.02 ± 3.33 | 5.8 ± 4.59 | <.001 | 4.13 ± 2.96 | 4.34 ± 2.67 | .174 | 1.58 (0.57, 2.58) | .003 |
Heart rate turbulence parameters | ||||||||
Turbulence onset | −0.0454 ± 0.0995 | −0.0673 ± 0.1044 | <.001 | −0.0486 ± 0.0876 | −0.0458 ± 0.0903 | .104 | −0.025 (−0.039, −0.010) | .001 |
Turbulence slope, ms/RR | 3.64 ± 4.77 | 5.22 ± 5.56 | <.001 | 3.97 ± 4.61 | 4.21 ± 5.14 | .129 | 1.348 (0.705, 1.991) | <.001 |
HRTc 0, n (%) | 12 (28.6) | 22 (52.4) |
.001 |
14 (36.8) | 16 (42.1) |
.223 |
N/A |
<.001 |
HRTc 1, n (%) | 19 (45.2) | 13 (31) | 15 (39.5) | 14 (36.8) | ||||
HRTc 2, n (%) | 11 (26.2) | 7 (16.6) | 9 (23.7) | 8 (21.1) | ||||
Clinical and laboratory findings | ||||||||
HbA1c, % | 7.81 ± 1.37 | 7.41 ± 1.17 | <.001 | 7.94 ± 1.31 | 7.5 ± 1.08 | <0.001 | −0.037 (−0.197, 0.122) | .645 |
Body weight, kg | 83.3 ± 13.8 | 81.0 ± 12.3 | <.001 | 81.7 ± 12.1 | 82.3 ± 11.9 | 0.195 | −2.92 (−4.18, −1.65) | <.001 |
Body mass index, kg/m2 | 29.6 ± 4.7 | 28.9 ± 4.3 | <.001 | 29.4 ± 5.0 | 29.6 ± 5.2 | 0.212 | −1.03 (−1.50, −0.56) | <.001 |
Systolic BP, mm Hg | 128.5 ± 19.9 | 122.7 ± 18.2 | <.001 | 129.3 ± 22.0 | 127.9 ± 18.5 | 0.394 | −5.7 (−7.8, −0.7) | .020 |
Diastolic BP, mm Hg | 77.9 ± 11.8 | 75.0 ± 11.4 | <.001 | 79.3 ± 14.6 | 78.8 ± 10.7 | 0.805 | −2.9 (−4.7, −1.0) | .086 |
Resting heart rate, beats/minute | 75.2 ± 11.4 | 76.1 ± 10.2 | .569 | 73.7 ± 10.6 | 72.9 ± 9.5 | 0.760 | 1.6 (−3.8, 7.1) | .349 |
Data presented as mean ± standard deviation. Statistically significant P-values are given in bold.
BP, blood pressure; HRTc, heart rate turbulence category; n, numbers; N/A, not available; pNN50, percentage of successive normal to normal (NN) intervals that differ by more than 50 milliseconds; PVBs, premature ventricular beats; RMSSD, root mean square of successive RR interval difference; SDANN, standard deviation (SD) of the average NN intervals for each 5-minute segment of the 24-hour recording; SDNN, SD of NN intervals; SDNN index, mean of the 5-minute SD of the NN interval calculated over 24 hours; ECG, electrocardiogram.